Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry

Atrial FibrillationHeart Failure

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Heart Rhythm

Yousuf O, Akar J, Tan Z, Alkalbani M, Tasneem H, Steinberg BA, Hsu JC, Atwater B, Yang E, Spertus J, Calkins H, Freeman JV

doi: 10.1016/j.hrthm.2025.06.048

Atrial Fibrillation

Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study

Circulation

Oldgren J, Hijazi Z, Arheden H, Björkenheim A, Frykman V, Janzon M, Ravn-Fischer A, Renlund H, Själander A, Åkerfeldt T, Wallentin L

doi: 10.1161/CIRCULATIONAHA.125.076725

Atrial FibrillationThrombosis and Stroke

Ablation of atrial fibrillation and risk of stroke: a Meta-analysis

Heart Rhythm

Providencia R, Ali H, Barra S, Creta A, Kukendra-Rajah K, Kanagaratnam P, Farkowski MM, Cappato R

doi: 10.1016/j.hrthm.2025.05.021

Atrial Fibrillation

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

J Am Heart Assoc

Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Olshansky B, Huisman MV, Lip GYH, GLORIA‐AF Investigators

doi: 10.1161/JAHA.125.044293

Atrial Fibrillation

Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF

J Am Coll Cardiol

Reddy VY, Gerstenfeld EP, Schmidt B, Nair D, Natale A, Saliba W, Verma A, Sommer P, Metzner A, Turagam M, Weiner S, Champagne J, Garcio-Bolao I, Calkins H, Olson J, Issa Z, Winner M, Su W, Tomassoni G, Kim J, Hook B, Delurgio DB, Gibson DN, Daccarett M, Patel C, Bhalla K, Shehata M, Harding JD, Cheung JW, Raybuck JD, Roelke S, Schwartz T, Sutton BS, Mansour M, ADVANTAGE-AF Investigators

doi: 10.1016/j.jacc.2025.03.515

Cardiovascular Risk and Diseases

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Cardiovasc Diabetol

Romiti GF, Mei DA, Corica B, Proietti M, Boriani G, Olshansky B, Chao TF, Huisman MV, Lip GYH, GLORIA-AF Investigators

doi: 10.1186/s12933-025-02950-y

Atrial Fibrillation

Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin

Circulation

Al Said S, Braunwald E, Palazzolo MG, Melloni GEM, Geller BJ, Ruff CT, Antman EM, Carnicelli AP, Eikelboom J, Granger CB, Patel MR, Wallentin L, Giugliano RP

doi: 10.1161/CIRCULATIONAHA.125.075275

Atrial FibrillationHeart, Artery and Coronary Diseases

Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial

Eur Heart J

Sanders P, Ariyaratnam JP, Stiles MK, Puvrez A, Nicholls SJ, Abhayaratna WP, Perrin MJ, Alison J, Pathak RK, Ganesan A, Paul V, Thomas SP, Thomas G, Middeldorp ME, Shahmohamadi E, Elliott AD, Park R, Haqqani H, Boddington D, Kistler PM, Martin P, Sy RW, Willems S, Stobie P, Webber M, Kaye G, MacIntyre P, John B, Steven D, Hussin A, Singarayar S, Whalley D, O'Donnell D, Lever N, Mahajan R, Ninio D, Amerena J, Esterman A, Chew DP, Worthley M, Tonkin A, De Pasquale CG, Kalman JM

doi: 10.1093/eurheartj/ehag206

Atrial FibrillationThrombosis and Stroke

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Heart Rhythm

Kaisaier W, Xu Z, Guo L, Dong Y, Chen Y, Lip GYH, Zhu W

doi: 10.1016/j.hrthm.2025.07.051

Related content

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study

Ablation of atrial fibrillation and risk of stroke: a Meta-analysis

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin

Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials